Complexes containing cationic and anionic pH-sensitive liposomes: Comparative study of factors influencing plasmid DNA gene delivery to tumors

International Journal of Nanomedicine

Volumn 8, Issue , 2013, Pages 1573-1593

  Chen, Yan ^a   Sun, Ji ^a   Lu, Ying ^a   Tao, Chun ^a   Huang, Jingbin ^a   Zhang, He ^a   Yu, Yuan ^a   Zou, Hao ^a   Gao, Jing ^a   Zhong, Yanqiang ^a  

^a SECOND MILITARY MEDICAL UNIVERSITY   (China)

Author keywords

Cationic liposomes; PDNA; Pegylated; PH sensitive liposomes; Transfection

Indexed keywords

3BETA[N (N',N' DIMETHYLAMINOETHANE)CARBOMOYL]CHOLESTEROL; 4',6 DIAMIDINO 2 PHENYLINDOLE; ANION; CATION; CHOLESTEROL DERIVATIVE; CHOLESTEROL HYDROGEN SUCCINATE; FLUORESCEIN ISOTHIOCYANATE; LIPOSOME; MACROGOL; PLASMID DNA; RHODAMINE; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; ATOMIC FORCE MICROSCOPY; CANCER GENE THERAPY; CELL VIABILITY; COMPARATIVE STUDY; COMPLEX FORMATION; CONFOCAL MICROSCOPY; CONTROLLED STUDY; DRUG ACCUMULATION; DRUG DOSAGE FORM COMPARISON; DRUG LABELING; DRUG TISSUE LEVEL; DRUG TUMOR LEVEL; GENE VECTOR; HUMAN; HUMAN CELL; IN VITRO STUDY; IN VIVO STUDY; LIPOSOMAL GENE DELIVERY SYSTEM; LIVER CELL CARCINOMA; MALE; MOUSE; NONHUMAN; NONVIRAL GENE DELIVERY SYSTEM; PARTICLE SIZE; PH; SINGLE DRUG DOSE; ZETA POTENTIAL;

CATIONIC LIPOSOMES; PDNA; PEGYLATED; PH-SENSITIVE LIPOSOMES; TRANSFECTION;

ANIMALS; CATIONS; CELL LINE, TUMOR; CELL SURVIVAL; DNA; ELECTROPHORETIC MOBILITY SHIFT ASSAY; HEP G2 CELLS; HUMANS; HYDROGEN-ION CONCENTRATION; LIPOSOMES; LIVER NEOPLASMS; MALE; MICE; MICE, INBRED BALB C; MICE, NUDE; MICROSCOPY, ATOMIC FORCE; PARTICLE SIZE; PLASMIDS; POLYETHYLENE GLYCOLS; TRANSFECTION; XENOGRAFT MODEL ANTITUMOR ASSAYS;

EID: 84876722062     PISSN: 11769114     EISSN: 11782013     Source Type: Journal    
DOI: 10.2147/IJN.S42800     Document Type: Article

References (24)

1. Bexell D, Scheding S, Bengzon J. Toward brain tumor gene therapy using multipotent mesenchymal stromal cell vectors. Mol Ther. 2010; 18(6):1067-1075.
2. Morille M, Passirani C, Vonarbourg A, Clavreul A, Benoit J P. Progress in developing cationic vectors for non-viral systemic gene therapy against cancer. Biomaterials. 2008;29(24-25):3477-3496.
3. Agarwal A, Unfer R, Mallapragada SK. Novel cationic pentablock copolymers as non-viral vectors for gene therapy. J Control Release. 2005;103(1):245-258.
4. Maitani Y, Igarashi S, Sato M, Hattori Y. Cationic liposome (DC-Chol/DOPE = 1:2) and a modified ethanol injection method to prepare liposomes, increased gene expression. Int J Pharm. 2007; 342(1-2):33-39.
5. Wasungu L, Hoekstra D. Cationic lipids, lipoplexes and intracellular delivery of genes. J Control Release. 2006;116(2):255-264.
6. Esposito C, Generosi J, Mossa G, Masotti A, Castellano AC. The analysis of serum effects on structure, size and toxicity of DDAB-DOPE and DC-Chol-DOPE lipoplexes contributes to explain their different transfection effciency. Colloids Surf B Biointerfaces. 2006; 53(2):187-192.
7. Salvati A, Ciani L, Ristori S, Martini G, Masi A, Arcangeli A. Physico-chemical characterization and transfection effcacy of cationic liposomes containing the pEGFP plasmid. Biophys Chem. 2006; 121(1):21-29.
8. Kim MJ, Lee HJ, Lee IA, et al. Preparation of pH-sensitive, long-circulating and EGFR-targeted immunoliposomes. Arch Pharm Res. 2008;31(4):539-546.
9. Tannock I, Rotin D. Acid pH in tumors and its potential for therapeutic exploitation. Cancer Res. 1989;49(16):4373-4384.
10. Drummond DC, Zignani M, Leroux J. Current status of pH-sensitive liposomes in drug delivery. Prog Lipid Res. 2000;39(5):409-460.
11. Simard P, Leroux JC. pH-sensitive immunoliposomes specific to the CD33 cell surface antigen of leukemic cells. Int J Pharm. 2009; 381(2):86-96.
12. Hiraka K, Kanehisa M, Tamai M, et al. Preparation of pH-sensitive liposomes retaining SOD mimic and their anticancer effect. Colloids Surf B Biointerfaces. 2008;67(1):54-58.
13. Legendre JY, Szoka FC Jr. Delivery of pDNA into mammalian cell lines using pH-sensitive liposomes: comparison with cationic liposomes. Pharm Res. 1992;9(10):1235-1242.
14. Karanth H, Murthy RS. pH-sensitive liposomes - principle and application in cancer therapy. J Pharm Pharmacol. 2007;59(4):469-483.
15. Venugopalan P, Jain S, Sankar S, Singh P, Rawat A, Vyas S P. pH-sensitive liposomes: mechanism of triggered release to drug and gene delivery prospects. Pharmazie. 2002;57(10):659-671.
16. Zhang Y, Li H, Sun J, et al. DC-Chol/DOPE cationic liposomes: a comparative study of the infuence factors on plasmid pDNA and siRNA gene delivery. Int J Pharm. 2010;390(2):198-207.
17. Farhood H, Serbina N, Huang L. The role of dioleoyl phosphatidy-lethanolamine in cationic liposome mediated gene transfer. Biochim Biophys Acta. 1995;1235(2):289-295.
18. Charudharshini S, Diane B. Optimization and characterization of anionic lipoplexes for gene delivery. J Control Release. 2009;136(1):62-70.
19. Hallaj-Nezhadi S, Lotfipour F, Dass C. Nanoparticle-mediated interleukin-12 cancer gene therapy. J Pharm Pharm Sci. 2010; 13(3):472-485.
20. Männistö M, Reinisalo M, Ruponen M, Honkakoski P, Tammi M, Urtti A. Polyplex-mediated gene transfer and cell cycle: effect of carrier on cellular uptake and intracellular kinetics and signifcance of glycosaminoglycans. J Gene Med. 2007;9(6):479-487.
21. Gao J, Sun J, Li H, et al. Lyophilized HER2-specifc PEGylated immunoliposomes for active siRNA gene silencing. Biomaterials. 2010; 31(9):2655-2664.
22. Knorr V, Ogris M, Wagner E. An acid sensitive ketal-based polyethylene glycol-oligoethylenimine copolymer mediates improved transfection effciency at reduced toxicity. Pharm Res. 2008;25(12):2937-2945.
23. Simões S, Moreira JN, Fonseca C, Düzgüneş N, de Lima MC. On the formulation of pH-sensitive liposomes with long circulation times. Adv Drug Deliv Rev. 2004;56(7):947-965.
24. Momekova D, Rangelov S, Lambov N. Long-circulating, pH-sensitive liposomes. Methods Mol Biol. 2010;605:527-544.